Safety of dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

REGISTRATION: PROSPERO: CRD42020210645 INTRODUCTION: We aimed to assess the safety of dipeptidyl peptidase-4 (DPP-4) inhibitors in older patients with type 2 diabetes with inadequate glycaemic control. METHODS: We included randomized controlled trials (RCTs) in older (⩾65 years) patients with type 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Doni, Katharina, Bühn, Stefanie, Weise, Alina, Mann, Nina-Kristin, Hess, Simone, Sönnichsen, Andreas, Pieper, Dawid, Thürmann, Petra, Mathes, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785305/
https://www.ncbi.nlm.nih.gov/pubmed/35111291
http://dx.doi.org/10.1177/20420986211072383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785305/
https://www.ncbi.nlm.nih.gov/pubmed/35111291
http://dx.doi.org/10.1177/20420986211072383

Ejemplares similares